The World Health Summit has proved itself the premier global health event of the year. Under the banner “Taking ...
FACT: #COVID19 is NOT airborne”, declared a tweet from WHO in March, 2020. WHO did not officially accept until almost 2 years later that infection by SARS-CoV-2 could after all be caused by long-range ...
The integration of Bruton tyrosine kinase (BTK) inhibitors into first-line treatment regimens, in combination with ...
The UK is facing a pharma exodus. Major pharmaceutical companies have withdrawn about £2 billion in proposed investment from ...
As the US foreign assistance architecture faces unprecedented dismantling, lessons from past crises take on urgent significance. Our new analysis of COVID-19 donor funding1 reveals a profound ...
International outcomes in breast, cervical, and ovarian cancers highlight opportunities to improve health-care delivery for ...
Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step ...
Cuts to international aid are risking the development of Asia's youngest democracy. Ted Alcorn reports from Dili.
Follicle-stimulating hormone (FSH), a glycoprotein secreted by gonadotroph cells of the anterior pituitary, is classically ...
Over the past two decades there have been tremendous advancements in the understanding of both the prevalence and the ...
Amid accelerating advances in artificial intelligence, the UK risks neglecting the biological foundations of natural ...
In the REC-CAGEFREE I trial by Chao Gao and colleagues,1 an open-label, randomised, non-inferiority trial comparing a drug-coated balloon (DCB) with a drug-eluting stent (DES) in patients with de novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback